Maintain BRK-B with staged re-entry at $489-$492; stop at $485, trim above $545
Maintain BRK-B at current exposure with stop at $485. The synthesis between aggressive (asymmetric cash floor, buyback resumption, 0.607 beta) and conservative (technical deterioration, 22.7x forward P/E, 13% YoY underwriting decline) analysts favors a neutral hold with staged re-entry rather than initiating new positions at spot. Allow the $489-$492 200 SMA confluence zone to test as support; enter incrementally with loosened momentum criteria rather than waiting for textbook confirmation. Trim 20-25% only on decisive weekly close above $545. The $365B cash position (34% of market cap), Q2 $4.21B buyback resumption, and Aaa-rated balance sheet provide structural floor that justifies maintaining exposure through technical weakness without adding at current prices.
| Position | Action |
|---|---|
| Decisive weekly close above $545 | Trim 20-25% |
| Pullback into $489-$492 with MACD histogram showing first signs of bottoming (slowing negative) and RSI holding above 40 | Add 25-33% of target incremental position |
| Confirmed 10 EMA reclaim at $506.76 with positive MACD histogram | Full incremental add |
| Sustained close below $485 on volume >4M | Underweight reassessment warranted |
BRK-B's 5.6% pullback to the 50 SMA represents a first test of a rising moving average within an intact structural bull market, creating a high-conviction asymmetric entry where downside is capped ~1.5-2% below at $489-492 while upside targets $537.74, supported by 108% YoY earnings growth, a resumed $4.21B buyback program, and $365.5B in deployable capital.
| Indicator | Value | Signal |
|---|---|---|
| close | 499.62 | neutral |
| 50_sma | 499.97 | bearish |
| 200_sma | 491.93 | bullish |
| 10_ema | 506.76 | bearish |
| rsi | 44.86 | neutral |
| macd | 1.57 | bearish |
| macd_signal | 4.18 | bearish |
| macd_histogram | -2.61 | bearish |
| bollinger_lower | 488.86 | bearish |
| bollinger_middle | 509.44 | neutral |
| bollinger_upper | 530.03 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: 10 EMA reclaim at $506.76 with positive MACD histogram
Then: Full incremental add
$365.5 billion cash position is a misunderstood strategic asset, not a shrinking war chest
↩ rebuts: “Cash hoard is shrinking and the Buffett premium is eroding”
EV: +7.6% to 52-week high at $537.74 · concedes: The technical setup is messy in the short term; 50 SMA test is unresolved near-term momentum; Insurance underwriting profit is down 13% YoY (competitive pressure is real); MACD is below its signal line
BRK-B is a falling knife at $499.62 with failed technicals, misleading valuation metrics, concentration risk in AI-exposed names at cycle highs, and macro asymmetry that favors downside over the next 60-90 days.
· concedes: Alphabet is a $2T+ firm with $100B+ free cash flow — the risk is multiple compression, not fundamental deterioration; One quarter of net buying is better than 14 quarters of net selling; The buyback does provide some demand-side price support; Berkshire's 60-year track record demonstrates capital allocation competence over time; The technical setup could reverse if price reclaims 10 EMA ($506.76) with MACD histogram turning positive
→ vs conservative: MACD histogram at negative 2.61 and failed 50 SMA test are mechanical triggers over-rotating at expense of structural picture; the 50 SMA test was a 35-cent violation (less than half a point) inside the bid-ask spread equivalent to a rounding error and doji on trend support, not a failure signal
→ vs conservative: Bearish MACD crossovers firing from overbought levels on low-volatility names historically resolve in V-shaped recoveries rather than sustained breakdowns; MACD decline for 7 straight sessions represents exhaustion, not initiation of new bearish move
→ vs conservative: 200 SMA rising every session in favor of long-term trend with price 7.69 points above it contradicts the bearish momentum narrative
→ vs neutral: Forward P/E of 22.7 is a fool's number that strips out mark-to-market gains which are the core of Berkshire's earnings power; TTM P/E of 12.56 with $365 billion in cash (34% of market cap) and 32.6% operating margins is not expensive
→ vs neutral: Insurance underwriting profit decline of 13 percent is contained (20-25% of earnings) and more than offset by float reinvestment yield in higher-for-longer rate environment with 85% probability of zero cuts through 2026
→ vs neutral: Burry calling something uninvestable is historically a contrary indicator for quality compounders, not a sell signal; he's wrong about quality low-beta compounders trading near intrinsic value
→ vs neutral: Sentiment at only 6.1 out of 10 is a gap created by Burry-style noise, which is opportunity not risk; waiting for confirmation at mixed signals framing turns high-conviction setup into missed opportunity
→ vs neutral: Housing bet of $6.8 billion at 0.6 percent of cash is asymmetric optionality not risk concentration; if soft-landing hits at 63% probability, the bet prints hard and Abel's contrarian deployment mirrors Buffett's 2008 bank positions
| atr | 7.94 | neutral |
| swing_high | 529.42 | neutral |
| swing_low_recent | 488.35 | neutral |
| volume | 3542880 | neutral |
| open | 503.41 | neutral |
| high | 507.06 | neutral |
| low | 499.45 | neutral |
Support: 488.86 · 491.93 · 499.97 | Resistance: 506.76 · 509.44
BRK-B closed at 499.62 on 2026-08-19, testing the 50 SMA at 499.97 as a pivotal support after a 5.63% pullback from the August 10 high of 529.42. The short-term trend is bearish (price below 10 EMA 506.76, MACD bearish crossover at 1.57 vs signal 4.18 with histogram at -2.61 and expanding), while the long-term trend remains bullish with price well above the rising 200 SMA at 491.93. RSI has cooled from overbought extremes (74.55 to 44.86) but hasn't reached oversold territory. If the 50 SMA fails, the next support confluence sits at 489-492 (200 SMA + Bollinger lower band). The transaction proposal is HOLD with recommended trailing stops at ~493 for existing longs; new positions should wait for either reclaim above 10 EMA or successful bounce from the 489-492 zone.
Market Cap
$1,069,541,425,152
52-Week High
$537.74
52-Week Low
$464.01
50-Day Moving Average
$499.72
200-Day Moving Average
$491.82
Beta (5Y monthly)
0.607
PE Ratio (TTM)
12.56
Forward PE
22.74
PEG Ratio
10.06
Price to Book
0.00096
EPS (TTM)
$39.78
Forward EPS
$21.97
Revenue (TTM)
$384.69B
Gross Profit (TTM)
$116.68B
EBITDA (TTM)
$130.68B
Net Income (TTM)
$85.77B
Operating Margin
32.56%
Profit Margin
22.30%
Return on Equity (ROE)
12.12%
Return on Assets (ROA)
6.01%
Free Cash Flow (TTM)
$71.98B
Total Assets (Q2 2026)
$1,263.07B
Cash & ST Investments (Q2 2026)
$365.51B
Cash & Cash Equivalents (Q2 2026)
$40.61B
Other ST Investments (Q2 2026)
$324.91B
Equity Investments LT (Q2 2026)
$323.78B
Investments & Advances (Q2 2026)
$685.67B
Net PPE (Q2 2026)
$244.14B
Total Equity (Q2 2026)
$747.91B
Total Debt (Q2 2026)
$128.60B
Long-Term Debt (Q2 2026)
$125.94B
Net Debt (Q2 2026)
$87.99B
Current Ratio (Q2 2026)
2.89
Debt to Equity (Q2 2026)
17.14
Tangible Book Value (Q2 2026)
$630.79B
FY 2022 Revenue
$234.12B
FY 2023 Revenue
$439.34B
FY 2024 Revenue
$424.23B
FY 2025 Revenue
$410.52B
FY 2022 Net Income
-$22.76B
FY 2023 Net Income
$96.22B
FY 2024 Net Income
$88.99B
FY 2025 Net Income
$66.97B
FY 2025 Diluted EPS
$31.04
FY 2025 Unrealized Loss on Investment Securities
-$39.98B
FY 2024 Unrealized Loss on Investment Securities
-$49.30B
FY 2023 Unrealized Loss on Investment Securities
-$69.14B
Q1 2025 Revenue
$83.29B
Q1 2025 Net Income
$4.60B
Q1 2025 Diluted EPS
$2.13
Q2 2025 Revenue
$98.88B
Q2 2025 Net Income
$12.37B
Q2 2025 Diluted EPS
$5.73
Q4 2025 Revenue
$111.44B
Q4 2025 Net Income
$19.20B
Q1 2026 Revenue
$92.07B
Q1 2026 Net Income
$10.11B
Q1 2026 Diluted EPS
$4.68
Q2 2026 Revenue
$117.89B
Q2 2026 Net Income
$25.67B
Q2 2026 Diluted EPS
$11.91
Q2 2026 Buybacks
$4.21B
Q1 2026 Operating CF
$10.44B
Q2 2026 Operating CF
$11.22B
Q1 2026 CapEx
-$4.99B
Q2 2026 CapEx
-$5.65B
Q1 2026 Free Cash Flow
$5.45B
Q2 2026 Free Cash Flow
$5.57B
Q1 2026 Buybacks
$0.24B
Q2 2026 End Cash Position
$41.36B
FY 2022 Operating CF
$37.35B
FY 2023 Operating CF
$49.20B
FY 2024 Operating CF
$30.59B
FY 2025 Operating CF
$45.97B
FY 2022 CapEx
-$15.46B
FY 2023 CapEx
-$19.41B
FY 2024 CapEx
-$18.98B
FY 2025 CapEx
-$20.93B
FY 2022 Free Cash Flow
$21.89B
FY 2023 Free Cash Flow
$29.79B
FY 2024 Free Cash Flow
$11.62B
FY 2025 Free Cash Flow
$25.04B
FY 2022 Share Repurchases
-$7.85B
FY 2023 Share Repurchases
-$9.17B
FY 2024 Share Repurchases
-$2.92B
FY 2025 Share Repurchases
$0
Strengths
Concerns
Berkshire Hathaway presents a high-quality defensive opportunity trading at a 12.56x TTM P/E (vs ~20-22x S&P 500) with a fortress balance sheet anchored by $365.51B in cash (~34% of market cap). Q2 2026 marked a pivotal inflection with record net income of $25.67B (+108% YoY) and aggressive $4.21B buyback resumption—management's clearest signal yet that shares trade below intrinsic value. With $685.67B in insurance float, conservative 17% leverage, and elite 32.56% operating margins across diversified businesses (insurance, railroads, utilities, manufacturing), Berkshire's "float + cash" optionality positions it for transformative M&A or sustained repurchases, offering asymmetric upside as a defensive portfolio anchor with PE-scale deployment ammunition.
Macro: Fed holding rates with 85% probability of no cuts in 2026; soft landing consensus at 63% (+9pp WoW); recession probability at 8% (-0.5pp WoW); long yields falling on Treasury buyback expansion; dollar weakened (global risk-on signal); oil elevated on Hormuz Strait standoff with no diplomatic progress; base metals higher — positive for BNSF freight and manufacturing subsidiaries.